T, T., F, W., FA, C., M, K., M, Q., & AK, K. (2026). Corrigendum to "Umbilical cord blood reduced relapse but increased non-relapse mortality compared to matched unrelated donor transplantation in pediatric AML with active disease: A CIBMTR 2008-2017 analysis of donor source and residual disease" Transplantation and Cellular Therapy (Volume 31, Issue 4, April 2025, Pages 261.e1-261.e15). Transplantation and cellular therapy. https://doi.org/10.1016/j.jtct.2026.03.002
Chicago Style (17th ed.) CitationT, Takahashi, Wachter F, Calderon FA, Kapadia M, Qayed M, and Keating AK. "Corrigendum to "Umbilical Cord Blood Reduced Relapse but Increased Non-relapse Mortality Compared to Matched Unrelated Donor Transplantation in Pediatric AML with Active Disease: A CIBMTR 2008-2017 Analysis of Donor Source and Residual Disease" Transplantation and Cellular Therapy (Volume 31, Issue 4, April 2025, Pages 261.e1-261.e15)." Transplantation and Cellular Therapy 2026. https://doi.org/10.1016/j.jtct.2026.03.002.
MLA (9th ed.) CitationT, Takahashi, et al. "Corrigendum to "Umbilical Cord Blood Reduced Relapse but Increased Non-relapse Mortality Compared to Matched Unrelated Donor Transplantation in Pediatric AML with Active Disease: A CIBMTR 2008-2017 Analysis of Donor Source and Residual Disease" Transplantation and Cellular Therapy (Volume 31, Issue 4, April 2025, Pages 261.e1-261.e15)." Transplantation and Cellular Therapy, 2026, https://doi.org/10.1016/j.jtct.2026.03.002.